Foundation, Novartis
Defining Optimal Immunotherapies for Type 1 Diabetes: Novartis Foundation Symposium
- This book is a comprehensive and up-to-date account of where we stand in immunological strategies for preventing or treating type 1 diabetes (T1D).
- Brings together contributions from the leaders in the arena of clinical immunotherapy, not limited to the diabetes field exclusively, in order to delineate a road-map that would lead to future clinical trials.
- The book integrates information from human and animal studies.
- The book considers T1D within the broader context of autoimmune disease.
- The format contains several discussions, which address specific questions and provides guidelines for future strategies and solutions for discovering a cure.
Keywords: Immunology, Cell & Molecular Biology, Immunology, Cell & Molecular Biology
- Author(s)
- Foundation, Novartis
- Editor
- Bock, Gregory R.
- Goode, Jamie A.
- Publisher
- John Wiley and Sons, Inc.
- Publication year
- 2008
- Language
- en
- Edition
- 1
- Series
- Novartis Foundation Symposia
- Page amount
- 222 pages
- Category
- Natural Sciences
- Format
- Ebook
- eISBN (PDF)
- 9780470697412
- Printed ISBN
- 9780470723258